Literature DB >> 12323371

Using steric hindrance to design new inhibitors of class C beta-lactamases.

Indi Trehan1, Federica Morandi, Larry C Blaszczak, Brian K Shoichet.   

Abstract

beta-lactamases confer resistance to beta-lactam antibiotics such as penicillins and cephalosporins. However, beta-lactams that form an acyl-intermediate with the enzyme but subsequently are hindered from forming a catalytically competent conformation seem to be inhibitors of beta-lactamases. This inhibition may be imparted by specific groups on the ubiquitous R(1) side chain of beta-lactams, such as the 2-amino-4-thiazolyl methoxyimino (ATMO) group common among third-generation cephalosporins. Using steric hindrance of deacylation as a design guide, penicillin and carbacephem substrates were converted into effective beta-lactamase inhibitors and antiresistance antibiotics. To investigate the structural bases of inhibition, the crystal structures of the acyl-adducts of the penicillin substrate amoxicillin and the new analogous inhibitor ATMO-penicillin were determined. ATMO-penicillin binds in a catalytically incompetent conformation resembling that adopted by third-generation cephalosporins, demonstrating the transferability of such sterically hindered groups in inhibitor design.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12323371     DOI: 10.1016/s1074-5521(02)00211-9

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  10 in total

1.  Identification of residues critical for catalysis in a class C beta-lactamase by combinatorial scanning mutagenesis.

Authors:  Shalom D Goldberg; William Iannuccilli; Tuan Nguyen; Jingyue Ju; Virginia W Cornish
Journal:  Protein Sci       Date:  2003-08       Impact factor: 6.725

2.  Structure-based optimization of a non-beta-lactam lead results in inhibitors that do not up-regulate beta-lactamase expression in cell culture.

Authors:  Donatella Tondi; Federica Morandi; Richard Bonnet; M Paola Costi; Brian K Shoichet
Journal:  J Am Chem Soc       Date:  2005-04-06       Impact factor: 15.419

Review 3.  β-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates.

Authors:  Montserrat Mora-Ochomogo; Christopher T Lohans
Journal:  RSC Med Chem       Date:  2021-08-04

Review 4.  Class C β-Lactamases: Molecular Characteristics.

Authors:  Alain Philippon; Guillaume Arlet; Roger Labia; Bogdan I Iorga
Journal:  Clin Microbiol Rev       Date:  2022-04-18       Impact factor: 50.129

Review 5.  Three decades of beta-lactamase inhibitors.

Authors:  Sarah M Drawz; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

6.  Inhibition of class A and C beta-lactamases by diaroyl phosphates.

Authors:  Sudipta Majumdar; R F Pratt
Journal:  Biochemistry       Date:  2009-09-08       Impact factor: 3.162

7.  Structural bases for stability-function tradeoffs in antibiotic resistance.

Authors:  Veena L Thomas; Andrea C McReynolds; Brian K Shoichet
Journal:  J Mol Biol       Date:  2009-11-10       Impact factor: 5.469

8.  Modified Penicillin Molecule with Carbapenem-Like Stereochemistry Specifically Inhibits Class C β-Lactamases.

Authors:  Xuehua Pan; Yunjiao He; Tianfeng Chen; Kin-Fai Chan; Yanxiang Zhao
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

9.  Variations within class-A β-lactamase physiochemical properties reflect evolutionary and environmental patterns, but not antibiotic specificity.

Authors:  Deeptak Verma; Donald J Jacobs; Dennis R Livesay
Journal:  PLoS Comput Biol       Date:  2013-07-18       Impact factor: 4.475

Review 10.  Glycosyltransferases and Transpeptidases/Penicillin-Binding Proteins: Valuable Targets for New Antibacterials.

Authors:  Eric Sauvage; Mohammed Terrak
Journal:  Antibiotics (Basel)       Date:  2016-02-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.